Burning Rock Biotech (BNR) EBIAT: 2020-2025
Historic EBIAT for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to -$2.4 million.
- Burning Rock Biotech's EBIAT rose 61.79% to -$2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.3 million, marking a year-over-year increase of 75.54%. This contributed to the annual value of -$47.5 million for FY2024, which is 48.42% up from last year.
- Burning Rock Biotech's EBIAT amounted to -$2.4 million in Q3 2025, which was down 72.35% from -$1.4 million recorded in Q2 2025.
- Burning Rock Biotech's EBIAT's 5-year high stood at -$1.4 million during Q2 2025, with a 5-year trough of -$41.2 million in Q1 2022.
- Its 3-year average for EBIAT is -$13.2 million, with a median of -$14.8 million in 2024.
- Per our database at Business Quant, Burning Rock Biotech's EBIAT crashed by 58.39% in 2021 and then soared by 90.66% in 2025.
- Over the past 5 years, Burning Rock Biotech's EBIAT (MRQ) stood at -$40.4 million in 2021, then increased by 14.07% to -$34.7 million in 2022, then increased by 28.75% to -$24.7 million in 2023, then soared by 60.82% to -$9.7 million in 2024, then surged by 75.46% to -$2.4 million in 2025.
- Its last three reported values are -$2.4 million in Q3 2025, -$1.4 million for Q2 2025, and -$1.9 million during Q1 2025.